The Asia-Pacific newborn screening market is, exhibiting a CAGR of 14.17%  between the years 2019-2027, owing to increasing birth rate, government programs supporting newborn screening, the rising the prevalence of diseases in newborn babies, and growing incidence of congenital disabilities.

ASIA PACIFIC NEWBORN SCREENING MARKET FORECAST 2019-2027

Asia Pacific Newborn Screening Market By Product (new-born Screening Instruments, New-born Screening Reagents & Assay Kits) By Test Type (hearing Screen Test, Critical Congenital Heart Disease (cchd) Test, Dry Blood Spot Test) By Technology (tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assays, Dna Based Assays, Electrophoresis, Others) By Geography.

Request free sample

The Asia-Pacific newborn screening market is, exhibiting a CAGR of 14.17%  between the years 2019-2027, owing to increasing birth rate, government programs supporting newborn screening, the rising the prevalence of diseases in newborn babies, and growing incidence of congenital disabilities.

The report on the Asia-Pacific newborn screening market mainly analyses the economies of countries like China, India, Japan, Australia and Rest of Asia Pacific. Rising instances of congenital disabilities in China have led its government to initiate programs supporting newborn screening.

The Government of India is implementing various health programmes which are expected to impact the newborn screening market positively. For instance, India Newborn Action Plan (INAP) is formulated for the prevention and care of a newborn with congenital disabilities. The Japanese newborn screening market accounted for the highest revenue share in 2017. The newborn screening market in Japan is primarily driven by a declining birth rate and increasing prevalence of congenital disabilities.

Significant challenges faced by the overall Asia-Pacific newborn screening market include issues like socio-economic barriers for the implementation of newborn child screening and a lack of proper healthcare infrastructure for newborn babies in some of its developing countries.

Noted companies in this region include Sciex, Biotek Instruments Inc., Bio-Rad Laboratories Inc., Cardinal Health Inc., GE Healthcare Limited, Agilent Technologies Inc., Masimo Corporation, Natus Medical Incorporated, Medtronic PLC, Thermo Fisher Scientific Inc., Neogen Labs Pvt. Ltd., Perkinelmer Inc., Zentech S.A., Waters Corporation and Trivitron Healthcare.

 

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE
      • STUDY GOALS
      • SCOPE OF THE MARKET STUDY
      • WHO WILL FIND THIS REPORT USEFUL?
      • STUDY AND FORECASTING YEARS
    2. RESEARCH METHODOLOGY
      • SOURCES OF DATA
        • SECONDARY DATA
        • PRIMARY DATA
      • TOP-DOWN APPROACH
      • BOTTOM-UP APPROACH
      • DATA TRIANGULATION
    3. EXECUTIVE SUMMARY
      • MARKET SUMMARY
      • KEY FINDINGS
        • DEMAND FOR NEWBORN SCREENING INSTRUMENTS IS RISING STEADILY
        • GROWTH IN DRY BLOOD SPOT TEST
        • TECHNIQUES USED IN NEWBORN SCREENING TESTS
    1. MARKET DYNAMICS
      • ETYMOLOGY OF NEWBORN SCREENING
      • MARKET SCOPE & DEFINITION
      • MARKET DRIVERS
        • INCREASE IN OCCURRENCES OF NEWBORN DISEASES
        • GROWING NUMBER OF INFANTS WITH BIRTH DEFECT
        • BACKING OF GOVERNMENT TOWARDS NEWBORN CHILD HEALTH
        • RISING AWARENESS FOR PEDIATRIC CONGENITAL HEART DISEASE
      • MARKET RESTRAINTS
        • ABSENCE OF PROPER HEALTHCARE INFRASTRUCTURE FOR NEWBORN BABIES IN DEVELOPING COUNTRIES
        • SOCIO-ECONOMIC HURDLES IN THE IMPLEMENTATION OF NEWBORN CHILD SCREENING
      • MARKET OPPORTUNITIES
        • INCREASING FERTILITY RATES ACROSS THE GLOBE IS CREATING DYNAMIC GROWTH
        • NEWBORN SCREENING HELPS IN EARLY IDENTIFICATION AND MANAGEMENT OF AFFECTED NEWBORNS
        • TECHNOLOGICAL ADVANCEMENTS IN NEWBORN SCREENING
        • INCREASE IN NUMBER OF PREGNANT WOMEN WITH ADVANCED MATERNAL AGE
      • MARKET CHALLENGES
        • DEARTH OF SKILLED PROFESSIONAL IN HEALTHCARE INDUSTRY
        • MAINTENANCE OF EQUIPMENT IN HOSPITAL
    1. MARKET BY PRODUCT
      • NEW-BORN SCREENING INSTRUMENTS
      • NEW-BORN SCREENING REAGENTS & ASSAY KITS
    2. MARKET BY TEST TYPE
      • HEARING SCREEN TEST
      • CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST
      • DRY BLOOD SPOT TEST
    3. MARKET BY TECHNOLOGY
      • TANDEM MASS SPECTROMETRY
      • PULSE OXIMETRY
      • ENZYME BASED ASSAYS
      • DNA BASED ASSAYS
      • ELECTROPHORESIS
      • OTHERS
    4. KEY ANALYTICS
      • PORTER’S FIVE FORCE MODEL
        • THREAT OF NEW ENTRANTS
        • THREAT OF SUBSTITUTE
        • BARGAINING POWER OF SUPPLIERS
        • BARGAINING POWER OF BUYERS
        • THREAT OF COMPETITIVE RIVALRY
      • KEY BUYING CRITERIA
        • RELIABILITY
        • COST
        • AVAILABILITY
        • TECHNOLOGICAL ADVANCEMENT
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • VALUE CHAIN ANALYSIS
        • RAW MATERIAL SUPPLIERS
        • MANUFACTURERS
        • DISTRIBUTORS
        • END-USERS
      • LEGAL, POLICY & REGULATORY FRAMEWORK
    5. ASIA PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    6. COMPETITIVE LANDSCAPE
      • MARKET SHARE ANALYSIS
      • CORPORATE STRATEGIES
        • PRODUCT LAUNCH
      • COMPANY PROFILES
        • SCIEX
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • BIOTEK INSTRUMENTS INC.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • BIO-RAD LABORATORIES INC.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • CARDINAL HEALTH INC.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • GE HEALTHCARE LIMITED
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • AGILENT TECHNOLOGIES INC.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • MASIMO CORPORATION
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • NATUS MEDICAL INCORPORATED
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • MEDTRONIC PLC
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • THERMO FISHER SCIENTIFIC INC.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • NEOGEN LABS PVT. LTD.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • PERKINELMER INC.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • ZENTECH S.A.
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • WATERS CORPORATION
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS
        • TRIVITRON HEALTHCARE
          • OVERVIEW
          • PRODUCT PORTFOLIO
          • STRATEGIC INITIATIVES
          • SCOT ANALYSIS

     

    TABLE LIST

    TABLE 1. ASIA PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

    TABLE 2. ASIA PACIFIC INCIDENCE OF CHROMOSOMAL ABNORMALITIES IN NEWBORNS

    TABLE 3. INFANT MORTALITY RATE IN DEVELOPING COUNTRIES (TOTAL DEATH/ 1000 LIVE BIRTHS)

    TABLE 4. ASIA PACIFIC NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027, (IN $ MILLION)

    TABLE 5. ASIA PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027, (IN $ MILLION)

    TABLE 6. ASIA PACIFIC NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027, (IN $ MILLION)

    TABLE 7. OPPORTUNITY MATRIX

    TABLE 8. VENDOR LANDSCAPE

    TABLE 9. REGULATORY FRAMEWORK

    TABLE 10. ASIA PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027, (IN $ MILLION)

    TABLE 11. LIST OF PRODUCT LAUNCHES

    FIGURE LIST

    FIGURE 1. ASIA PACIFIC NEW-BORN SCREENING INSTRUMENTS MARKET, BY TECHNOLOGY, 2018 & 2027 (IN %)

    FIGURE 2. CAUSES OF DEATH AMONG NEWBORNS ASIA PACIFIC (0-27 DAYS)

    FIGURE 3. FERTILITY RATE (AVERAGE BIRTHS PER WOMAN IN %) 2017

    FIGURE 4. ASIA PACIFIC NEWBORN SCREENING MARKET, BY NEW-BORN SCREENING INSTRUMENTS, 2019-2027 (IN $ MILLION)

    FIGURE 5. ASIA PACIFIC NEWBORN SCREENING MARKET, BY NEW-BORN SCREENING REAGENTS & ASSAY KITS, 2019-2027 (IN $ MILLION)

    FIGURE 6. ASIA PACIFIC NEWBORN SCREENING MARKET, BY HEARING SCREEN TEST, 2019-2027 (IN $ MILLION)

    FIGURE 7. ASIA PACIFIC NEWBORN SCREENING MARKET, BY CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST, 2019-2027 (IN $ MILLION)

    FIGURE 8. ASIA PACIFIC NEWBORN SCREENING MARKET, BY DRY BLOOD SPOT TEST, 2019-2027 (IN $ MILLION)

    FIGURE 9. ASIA PACIFIC NEWBORN SCREENING MARKET, BY TANDEM MASS SPECTROMETRY, 2019-2027 (IN $ MILLION)

    FIGURE 10. ASIA PACIFIC NEWBORN SCREENING MARKET, BY PULSE OXIMETRY, 2019-2027 (IN $ MILLION)

    FIGURE 11. ASIA PACIFIC NEWBORN SCREENING MARKET, BY ENZYME BASED ASSAYS, 2019-2027 (IN $ MILLION)

    FIGURE 12. ASIA PACIFIC NEWBORN SCREENING MARKET, BY DNA BASED ASSAYS, 2019-2027 (IN $ MILLION)

    FIGURE 13. ASIA PACIFIC NEWBORN SCREENING MARKET, BY ELECTROPHORESIS, 2019-2027 (IN $ MILLION)

    FIGURE 14. ASIA PACIFIC NEWBORN SCREENING MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)

    FIGURE 15. PORTER’S FIVE FORCE ANALYSIS

    FIGURE 16. KEY BUYING IMPACT ANALYSIS

    FIGURE 17. VALUE CHAIN ANALYSIS

    FIGURE 18. ASIA PACIFIC NEWBORN SCREENING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)

    FIGURE 19. CHINA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

    FIGURE 20. INDIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

    FIGURE 21. JAPAN NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

    FIGURE 22. AUSTRALIA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

    FIGURE 23. SOUTH KOREA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLIONS)

    FIGURE 24. REST OF ASIA PACIFIC NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

    FIGURE 25. INDUSTRY PLAYER POSITIONING IN 2018 (IN %)

    1. ASIA PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    2. MARKET BY PRODUCT
      • NEW-BORN SCREENING INSTRUMENTS
      • NEW-BORN SCREENING REAGENTS & ASSAY KITS
    3. MARKET BY TEST TYPE
      • HEARING SCREEN TEST
      • CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST
      • DRY BLOOD SPOT TEST
    4. MARKET BY TECHNOLOGY
      • TANDEM MASS SPECTROMETRY
      • PULSE OXIMETRY
      • ENZYME BASED ASSAYS
      • DNA BASED ASSAYS
      • ELECTROPHORESIS
      • OTHERS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type